Cipher Pharmaceuticals Inc
TSX:CPH

Watchlist Manager
Cipher Pharmaceuticals Inc Logo
Cipher Pharmaceuticals Inc
TSX:CPH
Watchlist
Price: 12.28 CAD -0.73%
Market Cap: 314.5m CAD

Intrinsic Value

The intrinsic value of one CPH stock under the Base Case scenario is 9.92 CAD. Compared to the current market price of 12.28 CAD, Cipher Pharmaceuticals Inc is Overvalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CPH Intrinsic Value
9.92 CAD
Overvaluation 19%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Cipher Pharmaceuticals Inc

Valuation History Unavailable

Historical valuation for CPH cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CPH?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Cipher Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cipher Pharmaceuticals Inc

Current Assets 40.1m
Cash & Short-Term Investments 22m
Receivables 11.8m
Other Current Assets 6.4m
Non-Current Assets 122.9m
PP&E 602k
Intangibles 94.5m
Other Non-Current Assets 27.9m
Efficiency

Free Cash Flow Analysis
Cipher Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cipher Pharmaceuticals Inc

Revenue
39.5m USD
Cost of Revenue
-11.1m USD
Gross Profit
28.4m USD
Operating Expenses
-21.2m USD
Operating Income
7.3m USD
Other Expenses
2m USD
Net Income
9.2m USD
Fundamental Scores

CPH Profitability Score
Profitability Due Diligence

Cipher Pharmaceuticals Inc's profitability score is 77/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Exceptional 3-Year Average ROE
Positive Operating Income
77/100
Profitability
Score

Cipher Pharmaceuticals Inc's profitability score is 77/100. The higher the profitability score, the more profitable the company is.

CPH Solvency Score
Solvency Due Diligence

Cipher Pharmaceuticals Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
69/100
Solvency
Score

Cipher Pharmaceuticals Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CPH Price Targets Summary
Cipher Pharmaceuticals Inc

Wall Street analysts forecast CPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CPH is 16.34 CAD with a low forecast of 13.13 CAD and a high forecast of 19.53 CAD.

Lowest
Price Target
13.13 CAD
7% Upside
Average
Price Target
16.34 CAD
33% Upside
Highest
Price Target
19.53 CAD
59% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cipher Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CPH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one CPH stock?

The intrinsic value of one CPH stock under the Base Case scenario is 9.92 CAD.

Is CPH stock undervalued or overvalued?

Compared to the current market price of 12.28 CAD, Cipher Pharmaceuticals Inc is Overvalued by 19%.

Back to Top